Evidence map›Paper›PMID 32033121›Full record

ArticleInternational journal of molecular sciences2020

Sphingolipid Signature of Human Feto-Placental Vasculature in Preeclampsia.

Ilaria Del Gaudio, Linda Sasset, Annarita Di Lorenzo, Christian Wadsack

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Tracing the Lipid Fingerprints of Preeclampsia.Reproductive sciences (Thousand Oaks, Calif.) · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Metabolomic prediction of severe maternal and newborn complications in preeclampsia.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ilaria Del GaudioDepartment of Obstetrics and Gynecology, Medical University of Graz, 8036 Graz, Austria.
Linda SassetDepartment of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.
Annarita Di LorenzoDepartment of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.
Christian WadsackDepartment of Obstetrics and Gynecology, Medical University of Graz, 8036 Graz, Austria.
Cornell University · USMedical University of Graz · AT

Funding

Endothelial Sphingolipid Synthesis and Tissue Inflammatory ResponseR01HL126913 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DI LORENZO, ANNARITA · 2015 to 2023
$3.5M
6 · The paper itself

Abstract

Bioactive sphingolipids are emerging as key regulators of vascular function and homeostasis. While most of the clinical studies have been devoted to profile circulating sphingolipids in maternal plasma, little is known about the role of the sphingolipid at the feto-placental vasculature, which is in direct contact with the offspring circulation. Our study aims to compare the sphingolipid profile of normal with preeclamptic (PE) placental chorionic arteries and isolated endothelial cells, with the goal of unveiling potential underlying pathomechanisms in the vasculature. Dihydrosphingosine and sphingomyelin (SM) concentrations (C16:0-, C18:0-, and C24:0- sphingomyelin) were significantly increased in chorionic arteries of preeclamptic placentas, whereas total ceramide, although showing a downward trend, were not statistically different. Moreover, RNA and immunofluorescence analysis showed impaired sphingosine-1-phosphate (S1P) synthesis and signaling in PE vessels. Our data reveal that the exposure to a deranged maternal intrauterine environment during PE alters the sphingolipid signature and gene expression on the fetal side of the placental vasculature. This pathological remodeling consists in increased serine palmitoyltransferase (SPT) activity and SM accrual in PE chorionic arteries, with concomitance impairment endothelial S1P signaling in the endothelium of these vessels. The increase of endothelial S1P phosphatase, lyase and S1PR2, and blunted S1PR1 expression support the onset of the pathological phenotype in chorionic arteries.

Indexed as

ArteriesCeramidesChorionEndothelial CellsEndothelium, VascularFemaleFetusGene ExpressionHumansLysophospholipidsMaternal-Fetal ExchangePlacentaPlacental CirculationPre-EclampsiaPregnancySignal TransductionCeramidesLysophospholipidssafingolSphingolipidsSphingomyelinsSphingosinesphingosine 1-phosphatebioactive lipidsfeto-placental endotheliumhuman placentaplacental vasculaturepreeclampsiasphingolipid metabolism

Identifiers

PMID32033121
PMCPMC7037072
OpenAlexW3005308306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.